Cargando…

Low GSTM3 expression is associated with poor disease‐free survival in resected esophageal squamous cell carcinoma

BACKGROUND: Glutathione S-transferase mu 3 (GSTM3) plays a crucial role in tumor progression in various cancers. However, the relationship between GSTM3 expression and the clinical prognosis of esophageal squamous cell carcinoma (ESCC) has not been studied to date. We aimed to characterize the role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fu, Wen, Jing, Luo, Kongjia, Fu, Jianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821639/ https://www.ncbi.nlm.nih.gov/pubmed/33482859 http://dx.doi.org/10.1186/s13000-021-01069-4

Ejemplares similares

Smoking Affects Treatment Outcome in Patients with Resected Esophageal Squamous Cell Carcinoma Who Received Chemotherapy
por: Zheng, Yuzhen, et al.
Publicado: (2015)

A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the Fibrinogen/Albumin Ratio
por: Tan, Zihui, et al.
Publicado: (2017)

miR-424 coordinates multilayered regulation of cell cycle progression to promote esophageal squamous cell carcinoma cell proliferation
por: Wen, Jing, et al.
Publicado: (2018)

NHE9 induces chemoradiotherapy resistance in esophageal squamous cell carcinoma by upregulating the Src/Akt/β-catenin pathway and Bcl-2 expression
por: Chen, Junying, et al.
Publicado: (2015)

Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma
por: Wen, Jing, et al.
Publicado: (2022)

Histone deacetylase 6 expression in metastatic lymph nodes is a valuable prognostic marker for resected node-positive esophageal squamous cell cancer
por: Xie, Xuan, et al.
Publicado: (2018)

Impact of alcohol consumption on survival in patients with esophageal carcinoma: A large cohort with long-term follow-up
por: Huang, Qingyuan, et al.
Publicado: (2014)

A Nomogram Model to Predict Post-Progression Survival in Esophageal Squamous Cell Carcinoma Patients With Recurrence After Radical Resection
por: Leng, Changsen, et al.
Publicado: (2022)

Skp2 expression unfavorably impacts survival in resectable esophageal squamous cell carcinoma
por: Liang, Yi, et al.
Publicado: (2012)

Low Preoperative albumin-to-globulin ratio Predict Poor Survival and Negatively Correlated with Fibrinogen in Resectable Esophageal Squamous Cell Carcinoma
por: Li, Xiao-Hui, et al.
Publicado: (2017)

Cyclin D1 expression predicts postoperative distant metastasis and survival in resectable esophageal squamous cell carcinoma
por: Hou, Xue, et al.
Publicado: (2016)

Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma
por: Guo, Jing, et al.
Publicado: (2022)

High FN1 expression is associated with poor survival in esophageal squamous cell carcinoma
por: Ma, Junliang, et al.
Publicado: (2022)

Low disabled-2 expression promotes tumor progression and determines poor survival and high recurrence of esophageal squamous cell carcinoma
por: Wang, Wen-Lun, et al.
Publicado: (2016)

Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma
por: Kim, Hyo Song, et al.
Publicado: (2014)

Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinoma
por: Sun, Peng, et al.
Publicado: (2016)

Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma: an observational study
por: Li, Kexun, et al.
Publicado: (2023)

Overexpression of Cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma
por: Chen, You-Fang, et al.
Publicado: (2013)

High Expression of GOLPH3 in Esophageal Squamous Cell Carcinoma Correlates with Poor Prognosis
por: Wang, Jian-Hua, et al.
Publicado: (2012)

TRPV6 plays a new role in predicting survival of patients with esophageal squamous cell carcinoma
por: Zhang, Shui-Shen, et al.
Publicado: (2016)

Real-world treatment patterns and survival for locally advanced esophageal squamous cell carcinoma
por: Luo, Hua-Chun, et al.
Publicado: (2023)

The Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Predicts Disease-Free Survival in Resectable Esophageal Squamous Cell Carcinoma
por: Zheng, Zhiwei, et al.
Publicado: (2021)

Low preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinoma
por: Huang, Ying, et al.
Publicado: (2015)

Surgically Resected Esophageal Squamous Cell Carcinoma: Patient Survival and Clinicopathological Prognostic Factors
por: Jeong, Dong Young, et al.
Publicado: (2020)

Conditional Survival of Patients Who Underwent Curative Resection for Esophageal Squamous Cell Carcinoma
por: Shin, Dong Wook, et al.
Publicado: (2022)

TNM Staging Matched-pair Comparison of Surgery After Neoadjuvant Chemoradiotherapy, Surgery Alone and Definitive Chemoradiotherapy for Thoracic Esophageal Squamous Cell Carcinoma
por: Liu, ShiLiang, et al.
Publicado: (2017)

Phenotypic profiling and prognostic significance of immune infiltrates in esophageal squamous cell carcinoma
por: Pan, Chuqing, et al.
Publicado: (2021)

High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma
por: Han, Na, et al.
Publicado: (2021)

Adjuvant Therapy for a Microscopically Incomplete Resection Margin after an Esophagectomy for Esophageal Squamous Cell Carcinoma
por: Qiu, Bo, et al.
Publicado: (2017)

Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma
por: Zhu, Zhengfei, et al.
Publicado: (2015)

Low preoperative albumin-globulin score predicts favorable survival in esophageal squamous cell carcinoma
por: Zhang, Fei, et al.
Publicado: (2016)

Effect of circumferential resection margin status on survival and recurrence in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy
por: Gu, Yi-Min, et al.
Publicado: (2022)

The high expression of MTH1 and NUDT5 predict a poor survival and are associated with malignancy of esophageal squamous cell carcinoma
por: Wang, Jing-Jing, et al.
Publicado: (2020)

High expression of MAGE-A9 is associated with unfavorable survival in esophageal squamous cell carcinoma
por: Qi, Yu, et al.
Publicado: (2017)

The impact of intratumoral metabolic heterogeneity on postoperative recurrence and survival in resectable esophageal squamous cell carcinoma
por: Dong, Xinzhe, et al.
Publicado: (2017)

Preoperative Prognostic Nutritional Index Predict Survival in Patients With Resectable Esophageal Squamous Cell Carcinoma
por: Zheng, Zhiwei, et al.
Publicado: (2022)

Elevated Preoperative NMPR Predicts an Unfavorable Chance of Survival in Resectable Esophageal Squamous Cell Carcinoma
por: Peng, Meng-Ying, et al.
Publicado: (2022)

Association of High Expression of Mitochondrial Fission Regulator 2 with Poor Survival of Patients with Esophageal Squamous Cell Carcinoma
por: Li, Hongwei, et al.
Publicado: (2021)

KIF-2C expression is correlated with poor prognosis of operable esophageal squamous cell carcinoma male patients
por: Duan, Hao, et al.
Publicado: (2016)

Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node‐positive esophageal squamous cell carcinoma: Is oral chemotherapy promising?
por: Fang, Shuogui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0iga13pq1cihi5djo0ik0j30us